podcast

Drug Fix: Oncology Stalwart Richard Pazdur Leaves US FDA

09.01.2026
Listen to the episode on your favorite platforms:
  • Apple Podcasts
  • Spotify
  • Castbox
  • Pocket Casts
  • iHeart
  • PlayerFM
  • Overcast
  • Castro
  • RadioPublic
PreVision Policy Founding Member Michael McCaughan joins Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs to discuss the career and legacy of Richard Pazdur, the long-time head of the US Food and Drug Administration’s oncology drug review division and Oncology Center of Excellence. They consider his brief stint as Center for Drug Evaluation and Research director and decision to retire (:55), his impact on oncology (), as well as reflect on his famous “Pazdur Moments” (), the future of legacy programs like Project Orbis (), and whether the FDA can find another leader like him (). 
 
More On These Topics From The Pink Sheet 
 
US FDA’s Richard Pazdur: Appreciating An Extraordinary Career: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fdas-richard-pazdur-appreciating-an-extraordinary-career-YD2GBQ7WOZHM5BNAKWJF4OQVFM/ 
 
Modernizing Accelerated Approval: One Of Pazdur’s Biggest Legacies: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/modernizing-accelerated-approval-one-of-pazdurs-biggest-legacies-4QPXDRZ7SNBE7EUOG5VWWILGDY/